STAVUDINE-CONTAINING SUSTAINED-RELEASE GRANULE Russian patent published in 2004 - IPC

Abstract RU 2239435 C2

FIELD: pharmacy.

SUBSTANCE: invention proposes medicinal formulations of stavudine with sustained-release effect comprising granules prepared by extrusion-spheronization and covered by isolating coating. Granules involve coating for sustained releasing also. Granules are prepared by mixing stavudine, spheronizing agent, suitable solvent, magnesium stearate taken in stabilizing amount in the presence of water taken in limited amount that is necessary for carrying out extrusion-spheronization process. Invention involves also solid gelatin capsules containing similar granules containing other therapeutic agents in addition to stavudine granules that are useful for retroviral infections. It has been shown that magnesium stearate, in contrast to other similar pharmaceutical additions, stabilizes stavudine against decomposition in hydrolysis and protects granules from color change from yellow to brown. Stavudine granules with magnesium stearate don't cause reducing activity of stavudine in hydrolysis that is associated with a method for their preparing.

EFFECT: improved preparing method, valuable pharmaceutical properties of granules.

33 cl, 3 tbl, 5 ex

Similar patents RU2239435C2

Title Year Author Number
FORM OF PROLONGED VENLAFAXINE HYDROCHLORIDE LIBERATION 2004
  • Bkhattacharja Sampad
  • Kshirsagar Radzhesh
  • Dzhoshi Majank
  • Pandita Sandip
RU2340331C2
TABLET WITH ENTEROSOLUBLE COATING AND METHOD OF PREPARING 1998
  • Ullakh Ismat
  • Uilej Gehri Dzh.
RU2201217C2
VITAMIN COMPOSITION WITH SUSTAINED-RELEASE OF ACTIVE COMPONENT 2001
  • Blok Jurgen
  • Khajm Shtefan
  • Vesterkhajde Ral'F
RU2248200C2
PHARMACEUTICAL ANTIRETROVIRAL COMPOSITION 2013
  • Malkhotra Dzhina
  • Purandare Shrinivas
RU2648457C2
CONTROLLED-RELEASE HYDROCODON COMPOSITION 2001
  • Oshlak Bendzhamin
  • Khuang Kh'Jua-Pin
  • Tonelli Al'Fred P.
  • Masselink Dzhon
RU2253452C2
PHARMACEUTICAL COMPOSITIONS OF METABOTROPIC GLUTAMATE RECEPTOR 5 (MGLU5) ANTAGONISTS 2011
  • Chetterdzhi Ashish
  • Khuan Tszintszjun
  • Kennings Shtefani
  • Lindenstrut Kaj
  • Sendkhu Kharprit K.
  • Shakh Navnit Khargovindas
RU2602955C2
NEW PHARMACEUTICAL COMPOSITION OF TAMSULOZIN AND DUTASTERIDE 2019
  • Daud, Anvar
  • Achliya, Girish
  • Maski, Nitin
  • Uodle, Shashikant
RU2795928C2
PHARMACEUTICAL COMPOSITION COVERED BY ENTEROSOLUBLE ENVELOPE AND METHOD OF ITS PREPARING 1998
  • Ullakh Ismat
  • Uilej Gehri Dzh.
RU2197227C2
METHOD FOR PREPARING ORAL PREPARATIVE FORM WITH PROLONGED EFFECT AND REGULATED RELEASE OF ACTIVE SUBSTANCE DEPENDING ON SPECIES AND AMOUNT OF STOMACH AND DIGESTIVE TRACT FILLING 1999
  • Kanikanti Venkata-Rangarao
  • Rupp Roland
  • Brehndel' Ehrikh
  • Vajzemann Klaus
  • Khantrajn Ehrnst
RU2235540C2
BALL SHAPED MEDICATIONS IN FORM OF PELLETS 2003
  • Strong Brajan
  • Klemkes Martin
  • Bakhmann Diter
RU2336863C2

RU 2 239 435 C2

Authors

Abramovits Rober

O'Donokh'Ju Deniz M.

Dzhejn Nemichand B.

Dates

2004-11-10Published

2001-03-29Filed